Down $2.05 from your claim it was headed to $15. That tell all of us, that you're a pumpettee. I'm holding for just a few more pennies, believe it will have difficulty breaking $5. Remember the second quarter is going to look bad. They are spending considerable more money on sgi-110, adding additional patients. You still looking at a $10M+ loss and the street maybe get a little spooked by this.
Buckettsht you must have taking writing lessons from Joseph Goebbels all propaganda . The street already knows what the second quarter will look like no surprises. Except maybe when the raise the yearly forecast because the generic hasnt shown up yet. You complain that Lee-011 trials are late and then you take a positive like expanded S-110 trials and try to turn it into a negative. Credibility is zero, We may have lost 2 bucks off the top so far but we're 4 bucks off the bottom. You are not too smart